🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 1 first-in-human single ascending dose study will be a randomize...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2015-08
Trial ID
NCT02531815
Treatments Being Tested
This is a phase 1, first in human, randomized, double-blind, placebo-contro...
Status
Completed
Location
Frontage Clinical Research Center
Start Date
2023-04-17
Trial ID
NCT05724797
This is a randomized, placebo-controlled, multiple dose escalation study to...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT03006159
To Evaluate the Safety, Tolerability and Pharmacokinetics on DA-302168S Tab...
Status
Completed
Location
Gulou Hospital Affiliated to Nanjing Medical University
Start Date
2024-04-18
Trial ID
NCT06534320
Treatments Being Tested
This is the first clinical trial with LEO 142397. The purpose of the trial ...
Status
Withdrawn
Location
Covance Clinical Research Unit Ltd.
Start Date
2019-07-03
Trial ID
NCT03995550
Treatments Being Tested
The purpose of this study is to examine the safety and tolerability of HFB3...
Status
Completed
Location
Huashan Hospital
Start Date
2021-05-09
Trial ID
NCT05275660
A safety study of KAN-101 in patients with celiac disease. The study has tw...
Status
Completed
Location
Anaheim Clinical Trials
Start Date
2020-01-21
Trial ID
NCT04248855
This is a prospective, double-blind, randomized, placebo-controlled study i...
Status
Terminated
Location
Sanford Health
Start Date
2020-05-14
Trial ID
NCT04372017
Treatments Being Tested
The purpose of this study is to determine whether NNZ-2566 is safe and effe...
Status
Completed
Location
University of South Alabama
Start Date
2010-04
Trial ID
NCT00805818
This is a Phase 1 study to assess the the safety, tolerability and pharmaco...
Status
Completed
Location
Research Site
Start Date
2022-04-04
Trial ID
NCT05351047
Treatments Being Tested